This is a CME-CPD accredited activity. Number of credits: 2
During this interactive debate organized by the International Society of Endocrinology (ISE) in partnership with the World Alliance of Pituitary Organizations (WAPO), two Key Opinion Leaders will talk about the common symptoms
of Adult GHD, the lack of consensus on the preferred diagnostic model, the common controversies around starting dosages, novel pharmacological therapies, the benefits and risks of continuing therapy, and important psychological and social well-being factors
faced by adult GHD patients.
Developed in collaboration with Dr Jens Otto Jorgensen (Denmark) and Dr Gudmundur Johannsson (Sweden).